Targeting HEDGEHOG Signaling and BRD4 for Melanoma Treatment | Oncotarget

Posted by

Oncotarget

Oncotarget published this trending editorial on May 26, 2023 in Volume 14, entitled, “Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma" by Silvia Pietrobono and Barbara Stecca from the Digestive Molecular Clinical Oncology Research Unit, University of Verona, Verona, Italy; Core Research Laboratory, Institute for Cancer Research and Prevention (CRL-ISPRO), Florence, Italy. DOI - https://doi.org/10.18632/oncotarget.28441 Correspondence to - Silvia Pietrobono - silvia.pietrobono@univr.it, and Barbara Stecca - b.stecca@ispro.toscana.it Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28441 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, melanoma, hedgehog signaling, BRD4, SOX2, GLI1 About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957